Cargando…
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
Posterolateral spinal fusion is the standard surgical approach for patients with degenerative disc disease. In our previously published article, we reported a 5-years follow-up of a phase I/II clinical trial in patients undergoing spinal fusion with autologous mesenchymal stem cells (MSCs) embedded...
Autores principales: | Gomez-Ruiz, Victoria, Blanco, Juan F., Villarón, Eva M., Fidalgo, Helena, López-Parra, Miriam, Sánchez-Guijo, Fermín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088196/ https://www.ncbi.nlm.nih.gov/pubmed/37038216 http://dx.doi.org/10.1186/s13287-023-03298-4 |
Ejemplares similares
-
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up
por: Blanco, Juan F., et al.
Publicado: (2019) -
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
por: Blanco, Juan F., et al.
Publicado: (2023) -
Autologous mesenchymal stromal cells embedded with Tissucol Duo(®) for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
por: Jiménez, Marcelo F., et al.
Publicado: (2023) -
Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
por: Campo, Arantza, et al.
Publicado: (2021) -
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)
por: Martin-Rufino, Jorge D., et al.
Publicado: (2018)